Neuproscan is an innovative AI tool for the early detection of pre-clinical Alzheimer's using MRI technology, designed to improve diagnosis accuracy and support proactive healthcare decisions.
How Neuproscan can help you:
- Improves the accuracy of MRI-based Alzheimer's diagnosis, reducing false positives and negatives.
- Makes early detection of Alzheimer's possible, enabling timely interventions.
- Facilitates more efficient use of healthcare resources by reducing unnecessary PET scans.
- Allows patients and families to plan for the future with more certainty.
- Enables participation in clinical trials for new treatments and therapies.
Why choose Neuproscan: Key features
- Utilizes advanced AI algorithms for early detection of Alzheimer's from MRI scans.
- Offers a fully customizable platform suitable for both individual doctors and hospitals.
- Capability to run on device or in the cloud, providing flexibility in operation.
- Supports the creation of custom AI models to meet specific diagnostic needs.
- Efficiently selects relevant slices from MRI scans for improved diagnostic precision.
Who should choose Neuproscan:
- Healthcare professionals looking for advanced diagnostic tools for Alzheimer's.
- Medical institutions seeking cost-effective alternatives to PET scans for Alzheimer's detection.
- Researchers and clinicians focused on early Alzheimer's intervention strategies.
- Families wanting early diagnosis for loved ones showing potential Alzheimer's symptoms.
